XML 40 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1

Earnings per share (Tables)

3 Months Ended

Mar. 30, 2024

Earnings Per Share [Abstract]

Schedule of Earnings Per Share

The following table sets forth the computation of basic and diluted loss per share of Class A common stock for the periods presented (amounts in thousands, except share and per share data):

			Three Months Ended
			March 30, 2024						April 1, 2023
Numerator:
Net loss from continuing operations, net of tax			$	(5,982)					$	(100,018)
Net loss attributable to noncontrolling interests — continuing operations			1,412						20,360
Net loss attributable to Bioventus Inc. Class A     common stockholders — continuing operations			$	(4,570)					$	(79,658)
Numerator:
Net loss from discontinued operations, net of tax			$	—					$	(74,429)
Net loss attributable to noncontrolling interests — discontinued operations			—						14,937
Net loss attributable to Bioventus Inc. Class A     common stockholders — discontinued operations			$	—					$	(59,492)
Denominator:
Weighted-average shares of Class A common stock outstanding - basic and diluted			63,380,187						62,124,752
Net loss per share of Class A common stock from continuing operations,     basic and diluted			$	(0.07)					$	(1.28)
Net loss per share of Class A common stock from discontinued operations,     basic and diluted			—						(0.96)
Net loss per share of Class A common stock, basic and diluted			$	(0.07)					$	(2.24)

Schedule of Antidilutive Securities

The following number of weighted-average potentially dilutive shares as of March 30, 2024 and April 1, 2023 were excluded from the calculation of diluted loss per share because the effect of including such potentially dilutive shares would have been antidilutive upon conversion:

			Three Months Ended
			March 30, 2024						April 1, 2023
LLC Interests held by Continuing LLC Owner(a)			15,786,737						15,786,737
Stock options			734,278						8,517,045
RSUs			1,479,188						1,070,105
Total			18,000,203						25,373,887

(a)Class A Shares reserved for future issuance upon redemption or exchange of LLC Interests by the Continuing LLC Owner.

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration